Skip to main content
. 2018 Jul 6;38(4):BSR20180553. doi: 10.1042/BSR20180553

Table 2.1. The characteristics of non-obese and obese adults according to the HAdV-36 antibody status*.

Non-obese Obese
HAdV-36 HAdV-36+ P HAdV-36 HAdV-36+ P
n 322 341 92 69
Age (years) 47.0 (39.0, 57.0) 45.0 (36.0, 53.0) 0.04 46.0 (38.0, 56.5) 47.0 (37.0, 57.0) 0.79
Male 168 (52.2%) 205 (60.1%) 0.04 65 (69.2%) 48 (69.6%) 0.96
Height (cm) 166.0 (159.4, 172) 167.6 (162.3, 172.9) 0.01 170.3 (161.8, 173.9) 168.3 (163.3, 173.0) 0.78
Weight (kg) 64.2 (57.4, 72.0) 67.1 (60.4, 74.2) 0.01 86.7 (78.1, 91.2) 83.9 (78.6, 90.8) 0.57
BMI (kg/m2) 23.7 (21.8, 25.4) 23.8 (22.2, 25.6) 0.25 29.9 (28.8, 31.0) 29.5 (28.4, 30.6) 0.12
WC (cm) 83.0 (77.0, 89.0) 84.0 (77.0, 89.0) 0.61 98.5 (93.5, 104.0) 96.0 (90.0, 101.0) 0.03
Systolic BP (mmHg) 124.0 (113.0, 135.0) 122.0 (111.0, 133.0) 0.07 132.0 (123.0, 146.5) 131.0 (122.0, 143.0) 0.46
Diastolic BP (mmHg) 77.0 (72.0, 83.0) 76.0 (72.0, 83.0) 0.05 82.0 (77.0, 89.0) 83.0 (78.0, 88.0) 0.87
TG (mg/dl) 1.2 (0.8, 1.8) 1.2 (0.9, 2.0) 0.07 1.6 (1.2, 2.2) 2.0 (1.1, 2.6) 0.45
TC (mg/dl) 4.8 (4.2, 5.4) 4.8 (4.3, 5.3) 0.51 4.9 (4.3, 5.3) 5.1 (4.5, 5.5) 0.07
LDL-c (mg/dl) 2.9 (2.5, 3.4) 3.0 (2.6, 3.4) 0.29 3.2 (2.6, 3.6) 3.4 (2.9, 3.7) 0.08
HDL-c (mg/dl) 1.3 (1.1, 1.5) 1.2 (1.1, 1.4) 0.43 1.1 (0.9, 1.3) 1.1 (1.0, 1.3) 0.55
GPT (U/l) 18.0 (13.0, 24.0) 18.0 (14.0, 25.0) 0.73 26.5 (18.5, 37.0) 24.0 (19.0, 32.0) 0.41
GOT (U/l) 25.0 (21.0, 29.0) 26.0 (22.0, 30.0) 0.01 28.0 (24.5, 32.0) 28.0 (24.0, 35.0) 0.84
TBIL (mmol/l) 12.6 (9.6, 16.4) 13.1 (9.8, 16.1) 0.78 12.2 (9.8, 16.0) 12.1 (9.7, 14.6) 0.76
Direct bilirubin (mmol/l) 4.0 (3.1, 5.4) 4.1 (3.3, 5.4) 0.85 4.3 (3.1, 5.3) 4.0 (3.3, 4.9) 0.53
Uric acid (μmol/l) 289.5 (238.0, 366.0) 313.0 (264.0, 369.0) 0.01 361.0 (299.5, 419.0) 375.0 (299.0, 426.0) 0.99
Glucose (mmol/l) 5.2 (4.9, 5.5) 5.2 (4.9, 5.6) 0.35 5.4 (5, 5.9) 5.3 (5.0, 5.6) 0.16
Carbamide 191.5 (4.9, 268.0) 5.2 (4.0, 188.0) <0.01 77.0 (4.7, 314.0) 8.1 (4.8, 319.0) 0.97
*

Variables are presented as median (IQR).